By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Dangerous/banned > GW501516 / Cardarine

GW501516 / Cardarine

GMJ
Last updated: 02/06/2026 18:42
By
Prof. Giorgi Pkhakadze
Share
6 Min Read
SHARE

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ Editorial Board

4 min read|830 words

What is GW501516 / Cardarine?

GW501516, commonly known as Cardarine, is a synthetic compound originally developed as a potential treatment for metabolic and cardiovascular diseases. Despite being marketed as a “selective androgen receptor modulator” (SARM) in supplement circles, GW501516 is actually a peroxisome proliferator-activated receptor delta (PPARδ) agonist, not a true SARM. It was developed by GlaxoSmithKline and Ligand Pharmaceuticals in the 1990s but never completed clinical trials due to serious safety concerns.

GW501516 is banned by the World Anti-Doping Agency (WADA) and is not approved by the FDA for human consumption. It is classified as a research chemical and is illegal to sell as a dietary supplement in many countries, including the United States.

Health benefits & uses

Evidence grade: Limited – All evidence comes from animal studies or incomplete human trials.

Submit Your Paper
GMJ_Submit_Banner

Preliminary research suggested GW501516 might offer several metabolic benefits, including improved fat oxidation, enhanced endurance, and better glucose tolerance. However, no completed human clinical trials have established safety or efficacy for any therapeutic use.

Animal studies indicated potential for:

  • Increased fat burning and weight loss
  • Enhanced endurance and exercise performance
  • Improved insulin sensitivity
  • Better lipid profiles

These findings have never been validated in properly controlled human studies, and the compound’s development was halted due to cancer risks observed in animal testing.

How it works

GW501516 activates PPARδ receptors, which are involved in regulating fat metabolism and energy expenditure. When activated, these receptors promote the expression of genes involved in fatty acid oxidation, potentially shifting the body’s energy utilization from glucose to fat. This mechanism theoretically could enhance endurance and promote fat loss.

The compound also appears to influence muscle fiber composition, potentially increasing the proportion of slow-twitch muscle fibers that are more efficient at burning fat for energy during prolonged exercise.

Dosage

No safe or effective dosage has been established for humans. GW501516 is not approved for human consumption, and there is no recommended daily allowance (RDA) or upper limit (UL) because it is not a recognized nutrient or approved medication.

Underground usage typically reports doses of 10-20mg daily, but these are based on anecdotal reports rather than scientific evidence. Any use should only occur under strict medical supervision as part of approved research protocols.

Food sources

GW501516 does not occur naturally in food sources. It is a synthetic compound created exclusively in laboratories. There are no dietary sources of this substance.

Safety & side effects

GW501516 poses serious safety risks and is considered dangerous for human consumption. Clinical development was terminated when animal studies revealed increased cancer rates, particularly colorectal, liver, bladder, stomach, and thyroid cancers.

Reported side effects and safety concerns include:

  • Cancer risk – Multiple tumor types in animal studies
  • Liver toxicity
  • Cardiovascular complications
  • Hormonal disruption
  • Unknown long-term effects on human physiology

The FDA has issued warning letters to companies selling GW501516, emphasizing that it is not safe for human consumption and cannot be legally marketed as a dietary supplement.

Interactions

Due to limited human research, comprehensive interaction data is unavailable. However, potential interactions may include:

Medications:

  • Diabetes medications – may affect blood glucose levels
  • Blood thinners – potential cardiovascular effects
  • Liver-metabolized drugs – due to hepatotoxicity risk

Supplements:

  • Other PPARδ agonists
  • Fat-burning compounds
  • Performance-enhancing substances

Who should be cautious

Everyone should avoid GW501516 due to its banned status and cancer risk. Particular caution applies to:

  • Athletes subject to drug testing
  • Individuals with cancer history or risk factors
  • People with liver disease
  • Those with cardiovascular conditions
  • Pregnant or breastfeeding women
  • Adolescents and young adults
  • Anyone taking prescription medications

Frequently asked questions

Is Cardarine legal to buy and use?

No, GW501516/Cardarine cannot be legally sold as a dietary supplement in the United States and many other countries. It’s banned by WADA for athletic competition and is considered unsafe for human consumption by regulatory agencies.

Why was Cardarine development stopped?

Clinical development was halted when animal studies showed increased cancer rates across multiple organ systems. The risk-benefit profile was deemed unacceptable for human use.

Are there safer alternatives for fat loss and endurance?

Yes, evidence-based approaches include proper nutrition, regular exercise, adequate sleep, and FDA-approved supplements when appropriate. Consult healthcare providers for safe, effective strategies.

What should I do if I’ve already used Cardarine?

Discontinue use immediately and consult a healthcare provider. Discuss any concerning symptoms and consider appropriate monitoring based on your usage history and risk factors.

Can Cardarine be detected in drug tests?

Yes, WADA-accredited laboratories can detect GW501516 and its metabolites. Use can result in positive drug tests and competition bans for athletes.

Classification:

Typical dose: — · Studied up to: —

References

Authoritative profile & live regulatory status: GW501516 / Cardarine on SupplementIndex →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Sleep loss triggers simultaneous damage across seven body systems, new evidence shows

Controlled studies show that restricting sleep to 4–6 hours per night for…

Why the ‘2pm coffee cutoff’ is a myth: genetics and lifestyle create a 15-fold range in caffeine metabolism

A new systematic review reveals that caffeine half-life varies 15- to 40-fold…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Calamus / Sweet Flag

By
Prof. Giorgi Pkhakadze
02/06/2026

Chaparral

By
Prof. Giorgi Pkhakadze
02/06/2026

Germanium (organic)

By
Prof. Giorgi Pkhakadze
02/06/2026

Belladonna

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up